Mother’s milk can shape the gut microbiota of very-low-birth-weight infants

The findings confirm that mother’s milk can deliver beneficial bacteria to very-low-birth-weight infants, with feeding practices and antibiotic use influencing this microbial exchange.

Gut dysbiosis and cancer: new insights into immunotherapy resistance and patient survival

Microbiomepost discussed with Lisa Derosa, oncologist at Gustave Roussy Hospital in Paris, about the link between gut dysbiosis and cancer, shedding light on its role in immunotherapy resistance and patient…

Trove of gut microbiotas reveals new compounds that may fight drug-resistant bacteria

The findings of a recent study highlight the potential of the human gut microbiota as a source for new antibiotics.

Antibiotic use during C-section has little impact on the infant gut microbiota

The findings suggest that while antibiotics can cause changes to the infant microbiota, they are much less significant than the impact of feeding mode.

Supporting women’s health through menopause: probiotic insights from IFF Health

Exploring probiotics for menopause with Maider Gutierrez, Business Development Lead for Women’s Health & Healthy Aging, IFF Health: solutions to support women's health and manage symptoms effectively.

Mouse study reveals that the microbiota influences bladder cancer

The findings suggest that the microbiota processes environmental carcinogens in ways that lead to cancer.

How diet affects the body and its microbiota

A deeper understanding of human biology, new dietary and medical interventions, and their effects on the microbiota may lead to more accurate and trustworthy dietary advice.

Exploring the biotechnological potential of bacteriocinogenic lactic acid bacteria

Microbiomepost conducted an exclusive interview with Svetoslav Todorov, from Sao Paulo University in Brazil, about the benefits of certain lactic acid bacteria.

Health Canada Authorizes Functional Claim for SynbÆctive® Femme, a Patented Probiotic Formula for Women’s Health

The recently patented probiotic combination specifically focused on women’s urogenital health.

European microbiome leaders unite to accelerate global therapeutic development

The partnership aims to accelerate the development and approval of microbiome-based therapeutics by harmonizing regulatory frameworks.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top